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1 Introduction
Cl in ica l research*1 has been def ined as 
“medical research for the purposes of improving 
preventive methods, diagnostic methods, and 
therapeutic methods for disease in medical 
t reatment, understand ing the causes and 
pathology of diseases, and improving the quality 
of life of patients, with human beings as its object 
(including research on materials and data of 
human origin which can designate individuals).”[1]
In short, however, clinical research is “research 
on human beings.” As such, it includes the 
“clinical tests”*2 used to investigate the safety and 
efficacy of candidate substances and practices in 
the development of new drugs and therapeutic 
methods. In th is, cl in ica l tests which are 
carried out in order to obtain approval for the 
manufacture and sale of pharmaceuticals, etc. 
from the Ministry of Health, Labour and Welfare 
are called “clinical trials.”*3
The creation of numerous new drugs and 
therapeutic methods through progress in clinical 
research has large direct benefits in maintaining 
and improving the health of Japanese citizens. 
In the coming years, Japanese elderly ratio 
(percentage of population 65 years of age or 
older to the total population) will increase, and 
will eventually exceed the level defining a “ultra-
aged” or “elderly-dominated” society (terms vary; 
but refer to an elderly ratio of 21% or higher). 
This means that activation of clinical research, 
including clinical trials and clinical tests, is an 
extremely important challenge for Japan.
At present, Japan is one of the small number 
of nations in the world with the capabi l ity 
to develop new drugs by own countr y. In 
2004, pharmaceutical products developed in 
Japan accounted for 13 of the world’s top 100 
pharmaceuticals in terms of sales value, ranking 
3rd behind the United States, which ranked 1st 
with 39 products, and the 2nd-ranking United 
Kingdom, with 14.[2] On the other hand, the 
percentage of Japanese papers published in 
leading journals on clinical research was lower 
than the percentage carried in journals such 
as “Nature” and “Science,” which publish high 
quality papers on basic research in the l i fe 
sciences.[3] These conditions can be considered to 
reflect the basic difficulty of clinical research in 
Japan, which can be attributed to the inadequate 
clinical research system in this country, and to 
the lack of a “translational system” for translating 
high quality basic research in the life sciences 
into clinical research. As another problem, it 
has also been pointed out that the system for 
reviews and clinical trials of pharmaceuticals 
is inadequate in comparison with those in the 
United States and Europe.
The common, fundamental issue for solving 
these various problems and activating clinical 
research in Japan is considered to be the training 
of clinical researchers. The main organizations 
engaged in cl inical research are university 
graduate schools, and the persons principally 
involved are physicians. Therefore, this paper 
will examine several interesting new training 
programs for human resources in the field of 
clinical research currently in progress in graduate 
school medical research departments, which 
have been developed for graduates from medical 
schools. In particular, the distinctive features of 
these programs are identified, the content of the 
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programs is discussed, and future policies for 
training clinical researchers are discussed.
2 Distinctive features of
 clinical research
Because its object of clinical research is human 
beings and materials of human origin, clinical 
research must consider safety and bioethics. In 
carrying out such research, it is necessary to 
follow various guidelines, as shown in Table 1.
Fu r ther more, the s i ng le te r m “c l i n ica l 
research” encompasses research for a variety 
of d i f ferent purposes, including “cl in ica l 
trials” for approval of pharmaceuticals and the 
like, “clinical tests” other than clinical trials, 
which are conducted, for example, to improve 
standard treatment methods, and “translational 
research (TR),”*4 which is a type of research 
bridging basic research and clinical research 
with the a i m of developi ng new med ica l 
technologies efficiently.[4] (See Table 2.) For 
this reason, the necessary guidelines will differ, 
depending on the type of cl inical research. 
Concretely, deta i led standards for cl in ica l 
trials are spelled out in Japan’s Pharmaceutical 
A f f a i r s L aw a nd the Ord i na nce on Good 
Clinical Practice (GCP; ordinance concerning 
standards for implementation of clinical trial of 
pharmaceuticals).
In addition, when considering human resources 
for activation of clinical research, appropriate 
human resource, development policies wil l 
differ depending on the type of clinical research. 
For example, the training policies for clinical 
research oriented “basic research” such as TR, 
are different from those for research which must 
be carried out in accordance with a process 
prescribed by a system, as in as clinical trials.
Table 1 : Representative laws, guidelines, etc. for clinical research
Law, guideline, etc.
Date of 
adoption or 
enforcement 
Body responsible for adoption, enforcement, etc.
Declaration of Helsinki (Ethical 
principles for medical research involving 
human experimentation)
June 1964 World Medical Association (WMA)
Ethical Guidelines for Clinical Research July 2003 Ministry of Health, Labour and Welfare (MHLW)
Guidelines for Clinical Research on 
Gene Therapy March 2002
Ministry of Education, Culture, Sports, Science and Technology (MEXT), 
MHLW
Ethical Guidelines for Research on 
Human Genome/Gene Analysis March 2001 MEXT, MHLW, Ministry of Economy, Trade and Industry (METI)
Ethical Guidelines for Epidemiological 
Research June 2002 MEXT, MHLW
Ideal Form of Research and 
Development using Human Tissue 
Obtained in Medical Operations, Etc.
December 
1998 Health Sciences Council (Report)
Guidelines for Establishment and Use of 
Human Embryonic Stem (ES) Cells 2001 MEXT (Notification)
Act concerning Protection of Personal 
Information May 2003
Common Ethical Review Guidelines for 
Translational Research
January 
2004
The University of Tokyo, Institute of Medical Science, Research 
Hospital, Advanced Clinical Research Institute; Nagoya University 
Hospital, Center for Regenerative Medicine; Kyoto University Hospital, 
Translational Research Center; Osaka University Hospital, Medical Center 
for Translational Research; Kyushu University Hospital, Department 
of Advanced Medical Engineering Therapeutics/Clinical Research 
Center; Foundation for Biomedical Research and Innovation, Institute 
of Biomedical Research and Innovation (IBMR)/Translational Research 
Informatics Center (TRI)
Guideline for Good Clinical Practice 
(Ministerial Ordinance; GCP Ordinance) March 1997
MHLW
*Related law: Pharmaceutical Affairs Law
Prepared by the STFC
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3 Types of clinical researchers
 required in the future
Var ious recom mendat ions and pol ic ies 
for science and technology pol icy related 
to the promotion of cl inical research were 
announced from 2006 to 2007. Here, four 
representative sets of recommendations will be 
discussed. (See section 3-1, (a) to (d).) These 
four sets of recommendations are divided into 
“Recommendations mainly concerning clinical 
resea rch” and “Recommendat ions ma in ly 
concerning clinical trials.” Types of the clinical 
researchers who will be required in the future of 
Japan will become apparent from the outline of 
these respective items and description of human 
resources for clinical research.
3-1 Recent recommendations and policies
(1)	 Recommendations	mainly	concerning
	 promotion	of	clinical	research	
(a)  In the field of Life Sciences in Promotional 
Strategies by Field (Cabinet Resolution of 
March 28, 2006)[5] in the Third Science 
and Technology Basic Plan laid out by the 
Japanese Cabinet’s Council for Science and 
Technology Policy (CSTP), “Translational 
research to clinical research and clinical 
t r i a l s” was se lec ted a s a S t r ateg ica l ly 
prioritized S&T for investment on a priority 
basis dur ing the per iod of the 3rd Plan 
(FY2006-FY2010). 
    The content of this research and development 
is shown below.
   •  Translational research, clinical research, 
and clinical trials contributing to the use of 
research results and innovative diagnostic and 
therapeutic methods aiming at early practical 
application, and to the use of pharmaceuticals 
and others which are generally used in other 
foreign countries but have not been approved 
in Japan.
   •  Improvement of the support system for 
clinical research and translational research.
   •  Training and securing human resources 
contributing to promotion of clinical research 
(including human resources with expertise in 
epidemiology and biostatistics).
   •  Research and development promot ing 
practical application of results, such as higher 
efficiency in the drug discovery process.
    As a policy for the Life Sciences field, the 
plan advocates “creation of a system for 
promoting clinical research,” and mentions 
that, “in order to return the results of research 
to the Japanese people in the form of new 
pharmaceutical products, medical equipment, 
etc., it is important to promote four efforts, 
namely, creating and strengthening the 
support system, securing and training clinical 
researchers and clinical research support 
personnel, creation of an environment for 
promoting research and examination and 
approval, and participation of the Japanese 
people.”
(b)  In December 2006, the Center for Research 
and Development Strategy (CRDS) of the 
Japan Science and Technology Agency (JST) 
published “Strategy Recommendations for 
Clinical Research —Aiming at Fundamental 
Reform of the Clinical Research System in 
Japan.”[6] This was followed by “Promotion 
of Integrative Celerity Research (ICR)— 
TR Physician-led clinical test Clinical trial
Purpose Efficient development of new 
medical technology
Innovation or improvement of 
standard therapeutic method
Application/approval of new 
medical technology
No. of subjects Small Small to Large Small to Large
Leader Researcher or Physician Physician Private company or Physician
Source of research funds
National government, private 
company, venture capital, 
researcher
Private company, national 
government, researcher Private company
Supplier of reagents/test 
product
Researcher, private company, 
national government Private company Private company
Table 2 : Comparison of translational research (TR), Physician-led clinical tests, and clinical trials
From Reference [4]
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Innovation in Health and Medical Care” in 
March 2007.[7]
    It is assumed that “a wealth of knowledge 
on the life sciences is being accumulated as 
a result of substantial investment in basic 
research in the life sciences, but because the 
system for implementing clinical research 
is weak, and there are also problems in the 
organizations responsible for review and 
approval (of pharmaceuticals), it is difficult 
to translate the results of basic research into 
practical applications quickly.” Therefore, 
fundamental reform of the clinical research 
system and the review and approval system is 
recommended.
    Concrete recommendat ions include 
“Establishment of Clinical Research Basic 
Law,” which positions clinical research as one 
of the most critical items for national policy, 
“Creation of centers for clinical research, 
establishment of composite clinical research 
bodies, and formation of a network” to enable 
researchers in different fields to routinely 
create cooperat ive systems by placing 
the functions of basic research, cl inical 
research, and advanced medical research and 
development in one location, and “Measures 
for promoting Integrative Celerity Research 
(ICR): Securing funds, systemic reform, and 
training of human resources.”
(2)	 	Recommendations	mainly	concerning	activation	
of	clinical	trials
(c)  In the area of clinical research in Japan, 
including clinical trials, the Expert Panel on 
Basic Policy in the Cabinet’s above-mentioned 
Council for Science and Technology Policy 
positioned “el imination of systemic and 
administrative obstacles to smooth science 
and technology activit ies and return of 
results” as one necessary issue. A review was 
begun in June 2006, and an interim report 
was issued on July 26, 2006.[8]
    In the report, the following are mentioned 
a s  d i r e c t i o n s i n r e f o r m s f o r  s y s t e m 
improvement.
   •  Creat ion and strengthening of suppor t 
systems, etc.
   •  Securing and training clinical researchers and 
clinical research support personnel.
   •  I mprovement o f t he env i ron ment for 
promoting research and review/approval 
( i mp r ove m e nt o f  t h e f r a m e wo r k fo r 
promoting clinical research, improving speed 
and efficiency in reviews and approvals of 
pharmaceutical products, etc., and joint 
international clinical trials).
   •  Pa r t ic ipa t ion o f t he Japa nese people 
(deregulation of information distribution 
activity on cl inical tr ials, incentives for 
subjects in clinical research).
(d)  On March 30, 2007, MEXT and the Ministry 
of Health, Labour and Welfare announced a 
“New 5-Year Clinical Trial Activation Plan.”[9] 
This corresponds to the following plans in the 
“National 3-Year Clinical Trial Activation Plan” 
adopted in April 2003.
    In the New 5-Year Clinical Trial Activation 
Plan, the following items are mentioned as 
issues for achieving a higher level of activity 
in clinical trials and clinical research.
   •  Creation of a system of core hospitals and 
base medical institutions.
   •  Training and securing human resources to 
implement clinical trials and clinical research.
   •  Popular ization to and enl ightenment of 
the Japanese people, and promotion of 
participation in clinical trials and clinical 
research.
   •  Efficient implementation of clinical trials and 
alleviation of the burden on private business.
   •  Other issues (elimination of obstacles to 
joint international cl inical tests/cl inical 
research, study of a system for reporting the 
start of clinical research, review of “Ethical 
Guidelines for Clinical Research,” and other 
matters related to review of “Ordinance on 
Good Clinical Practice (GCP),” etc.).
3-2 Content of recommendations on training
 of human resources for clinical research
All of the recommendations discussed in the 
previous section 3-1 mentioned items related 
to the training of human resources for clinical 
research. These will be discussed in detail in the 
following.
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The above-mentioned item (a) recommended 
s ec u r i ng a nd t r a i n i ng hu m a n re sou rce s 
to suppor t cl in ica l research (cl in ica l tr ia l 
co o r d i n a t o r s ,  b i o s t a t i s t i c i a n s ,  c l i n i c a l 
epidemiologists, pharmacists, data managers, 
etc.). A huge number of data are generated in 
clinical research. In order to interpret these 
data and determine the subsequent direction of 
research, clinical research support personnel 
who manage and perform statistical analyses 
of these data are necessary and indispensable. 
The recommendations for securing (and hiring) 
this number of clinical researchers and clinical 
research support personnel include improvement 
of education for this purpose and providing 
career paths and economic incent ives for 
researchers.
Although (a) did not present concrete policy 
recommendations on the training of clinical 
research personnel for the physicians, who are 
the main persons carrying out clinical research, 
the following may be mentioned as concrete 
efforts related to the item “Creation of a support 
system for cl in ica l research/translat iona l 
research.”
   •  Efforts not only to develop “seeds” from basic 
research to clinical development, but also 
to tie “seeds” from the clinical viewpoint to 
basic research.
   •  Collection of information on world trends, 
such as new technique and research efforts in 
clinical research, and so on, and study of the 
application of those techniques/research.
   •  Expansion and strengthening of joint systems 
between physicians and researchers in basic 
medical science and other fields (in particular, 
engineering-related and pharmacology-related 
fields). 
   •  Creation of facilities, institutes, and networks 
for search-type development of candidate 
substances for pharmaceutical products 
and implementation of the search for such 
substances, and improvement of the research 
infrastructure, including cell/tissue banks, 
specialized non-clinical test facilities, etc.
Although these are mentioned in connection 
with the research support system, if “research 
infrastructure” in the final item is changed to 
“training of clinical researchers,” virtually the 
same language describes a human resources 
training policy, as follows:
   •  Tr a i n i ng o f c l i n ica l r e sea rcher s who 
implement research which not only develops 
the “seeds” from basic research to clinical 
research, but also tie “seeds” from the clinical 
viewpoint to basic research.
   •  Training of clinical researchers who grapple 
actively with new techniques and research in 
clinical research.
   •  Training of clinical researchers who can 
act ively implement joint research with 
physicians and researchers in basic medical 
science and researchers in other fields.
As human resources which are indispensable 
for promot ing cl in ica l research, i tem ( b) 
mentioned physicians who carry out clinical 
research, biostatisticians, human resources 
with a knowledge of regulatory science, data 
managers, clinical trial coordinators, human 
resources work ing in genomics and other 
technologies, human resources working in 
informatics, human resources promoting medical-
engineering collaboration (information science, 
nanobiology, engineering), and human resources 
in the areas of intellectual property and legal 
affairs. In addition, it is also necessary to improve 
and expand graduate schools of public health 
for comprehensive education of these human 
resources.
Next, assuming that it is necessary to train 
the physicians who carry out clinical research 
in medical schools and graduate schools, the 
followings are mentioned as concrete measures.
   •  Improvement of the c l i n ica l resea rch 
curriculum in medical school education.
   •  E d u c a t i o n  i n  c l i n i c a l  r e s e a r c h  a n d 
implementation of research in graduate 
schools.
   •  Establishment of post-doctoral fellowships for 
physicians involved in clinical research.
   •  Education in summer schools and the like in 
clinical research centers as on-the-job training 
(OJT).
   •  Establishment of an evaluation system which 
provides incentives to physicians participating 
in clinical research.
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As in item (a), (c) also refers to training/
securing clinical research support personnel. 
However, in addition to this, it also mentions the 
followings as problems related to the training of 
the physicians responsible for clinical research.
   •  I n a d e q u a c y o f  hu m a n r e s o u r c e s f o r 
cl inical research: As the causes of this, 
because universities tend to prioritize basic 
exper imenta l medica l science, cl in ica l 
trials and clinical research tend to be a less 
important priority. Moreover, because the 
latter types of work require time, they do not 
lead to promotions, and as a result, university 
researchers tend to avoid these fields. 
   •  The weakness of universities, hospitals, 
research institutes, and others that educate/
train human resources for clinical research is 
also a problem.
Where training of cl in ical researchers is 
concerned, the followings were recommended in 
(c):
   •  Universit ies should shi f t education and 
research to fields closer to clinical research.
   •  It is necessary to create an environment in 
which clinical researchers are fairly evaluated 
as specialists, and to establish a career path 
which reflects their actual performance in 
clinical research.
Item (d) recommends concrete measures 
in connection with incentives for physicians 
engaged in clinical trials and clinical research:
   •  Urge cooperation in core hospitals, base 
medical institutions, and related bodies 
in order to improve the evaluation of the 
cl in ical per formance of physicians and 
others (including their treatment in hospitals, 
eva luat ion of academic society papers, 
acquisition of degrees).
   •  Shift the share of Health and Labour Sciences 
Research Grants and other grants from basic 
research to clinical trials and clinical research 
in order to popularize clinical trials/clinical 
research.
   •  Secure and increase oppor tun it ies for 
education related to clinical trials and clinical 
research in the curriculum for physicians and 
related professions.
   •  Make it possible for physicians and others 
involved in clinical trials and clinical research 
to secure time and financial resources for 
research.
3-3 Types of clinical researchers required in
 the future
Summarizing the foregoing discussion, it is 
thought that the following four types of clinical 
researchers will be required in the future:
(A)  Researchers who have strong ability in 
both basic research and clinical research.
(B)  Researchers who are or iented toward 
collaborative/interdisciplinary work with 
other fields.
(C)  Specialists in clinical research as such.
(D)  Researchers who play a leadership role in 
implementing clinical trials.
4 Graduate school programs
 for training human resources
 for clinical research
First, the current problems in training human 
resources for cl inical research in Japanese 
graduate schools will be discussed in section 
4-1. Next, section 4-2 describes human resources 
development programs in graduate schools 
supported by the national government. Section 
4-3 presents an outline of the human resources 
development programs in graduate school 
medical science departments selected under 
the national programs in 4-2, focusing on those 
which appear to be capable of training the 
“clinical researchers required in the future.”
4-1 Current problems in postgraduate
 training of human resources for clinical
 research 
Because clinical research centers on research 
through medical treatment, clinical researchers 
should desirably be persons who possess the 
fundamental knowledge and skills required in 
physicians and who have also received training 
as researchers. It is also necessary to train a 
large number of clinical researchers of this type. 
However, a substantially long period of time is 
required for a physician to become a clinical 
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researcher.
After completing 6 years of medical education 
(medical school) in order to acquire the basic 
knowledge, skills, etc. necessary in physicians, 
physicians are lega l ly requi red to receive 
2 years of cl in ical training under the New 
Postgraduate Medical Training System, which 
was established in April 2004, so as to master a 
wide range of basic medical capabilities. Then, 
in order to acquire qualification as a specialist 
(physician who has received education and 
training satisfying speci f ied standards in a 
designated clinical field or disease and passed 
a test in this specialization), some physicians 
receive specialized medical training for 3-5 years 
following New Postgraduate Medical Training. 
If a physician wishes to go on to graduate 
school with the aim of becoming a researcher, 
he or she must first complete New Postgraduate 
Medical Training. This means that medical 
researchers begin their careers considerably later 
than researchers in other fields. Moreover, it has 
been reported that persons 30-34 years of age are 
the largest age group currently entering graduate 
schools [10], suggesting that many physicians 
actually complete specialized medical training 
before going on to graduate school.
The Final Report of the “Cooperating Members 
Committee on Studying Improvement of Medical 
Education (MEXT)[10] of fered the fol lowing 
recommendations for improving graduate school 
education based on these point as above.
   •  Clar i f ication of the purpose of graduate 
school (training of researchers and training 
of Physicians), and positioning of medical 
occupations for research purposes in the 
university hospital in the graduate school 
curriculum.
   •  Implementation of autumn admissions in 
order to al low physicians adequate time 
to prepare to enter graduate school after 
complet ing New Postgraduate Medica l 
Training.
   •  Establishment of a graduate school course 
allowing early advance to graduate school 
without receiving New Postgraduate Medical 
Training.
  (A s  e x a m p l e s  o f  e a r l y  a d v a n c e m e n t 
to graduate school, 17 un iversit ies are 
attempting to establish MD/Ph.D. courses 
in which persons who have completed 
the cred it s requ i red by the un ivers it y 
with outstanding records are al lowed to 
enter graduate school medical research 
departments after completing their fourth 
year of medical school, and then, upon 
completing their Ph.D., are readmitted to 
the 5th year of medical school, and go on 
graduate.)
   •  Incorporation of training intended to develop 
a “researcher’s mentality” for personal career 
path to become educators or researchers 
in the future in the training period other 
than the basic training courses of the New 
Postgraduate Medical Training and required 
courses.
   •  Improvement of graduate school efforts to 
train medical special ists by cooperation 
between graduate schools and university 
hospitals.
   •  Efforts to give a real feeling that receiving 
the Ph.D. degree is the “starting line” for 
educators and researchers.
   •  Clarification of the respective career paths 
for physicians, clinical researchers, and basic 
medical researchers, and support for career 
formation.
If the merits and incentives for physicians 
going on to graduate school are not clear, there is 
concern that the number of persons going on to 
postgraduate education will decline in the future.
4-2 Clinical researcher training programs in
 nationally-supported graduate schools
As “Support for University Education Reform 
th roughout Nat iona l , Publ ic, and Pr ivate 
Universities,” MEXT provides support for selected 
programs with distinctive features at universities 
and graduate schools. The budget for these 
activities was ¥60.2 billion in FY2007, up from 
¥56.2 billion in FY2006.[11]
This includes “Creation of the World’s Highest 
Level Education and Research Centers with 
International Competitiveness (Global COE, 
21st Century COE Program),” “Promotion of 
Training of Persons in Specialized Occupations 
Responding to Socia l Needs (Program for 
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Promotion of Education in Specialized Graduate 
Schools, Etc., Program for Promotion of Training 
of High Quality Medical Personnel Responding 
to Regional Medicine and other Social Needs, 
Cancer Professional Training Program),” “Training 
of Human Resources Capable of Responding 
to Contemporary Issues and Development of 
Diverse Functions of Universities (Contemporary 
Educational Needs Support Program, University 
Educat ion Internat iona l izat ion Promotion 
Program, Program for Promotion of Education 
Responding to Adu lt Reeducat ion Needs, 
Student Support Program Responding to New 
Socia l Needs),” “Advancement/Enr ichment 
o f  E d u c a t i o n a l  C o n t e n t / M e t h o d s ,  E t c . 
Corresponding to Courses (Distinctive University 
Education Support Program, Graduate School 
Educational Reform Support Program, Initiatives 
for Attractive Education in Graduate Schools: 
Table 3).”
The fol lowing wil l discuss the programs, 
among those mentioned above, which also 
funct ion as t r a in ing programs for human 
resources in the field of clinical research.
(1)	 “Initiatives	for	Attractive	Education	in	Graduate
	 	 Schools”[12]
The “Initiatives for Attractive Education in 
Graduate Schools” program (MEXT, Higher 
Education. Bureau, University Promotion Division, 
and Japan Society for the Promotion of Science) 
is a support program which gives priority to 
active and original graduate school educational 
programs aimed chief ly at training of young 
researchers responding to social needs.
In this program, among the medical topics 
selected in 2005 (19 items) and 2006 (11 items), 
themes of educational programs related to 
clinical research were selected, as shown Table 
4. Examples of these will be discussed in the 
following section 4-3.
Table 3 : Outline of the “Initiatives for Attractive Education in Graduate Schools” program
“Initiatives	for	Attractive	Education	in	Graduate	Schools”
(Outline)
	 •	 	Provides	prioritized	 support	 for	 educational	programs	 to	 enable	 young	 researchers	 to	 acquire,	 in	
an	organized	and	 systematic	manner,	 the	 attributes	newly	 required	 in	young	 researchers	 and	 the	
capability	 to	 carry	our	 research	 activities	 independently,	 and	promotes	 strengthening	of	 researcher	
training	functions.
	 •	 	Promotes	 strengthening	of	organizational	development	of	educational	 issues	and	pioneering	of	new	
research	guidance	methods	from	the	viewpoint	of	advancing	graduate	school	education	responding	to	
the	needs	of	the	times.
(Applicable	objects)
	 	 In	principle,	applied	to	the	course	having	a	doctoral	program.
(Scale	of	project)
	 •	 	The	amount	of	grants	provided	by	 the	national	government	has	 an	upper	 limit	of	 \50	million/year	
for	each	item	within	the	scope	of	the	program	scale,	considering	its	content,	etc.,	and	in	principle	is	
provided	continuously	for	2	years.	
(Budget)
	 	 Budget	for	fiscal	year	2006:	\4.2	billion	(for	FY2005:	\3.0	billion).
(Record	of	awards)
	 •	 	FY2006:	268	applications	were	received	from	129	universities;	of	these,	46	items	from	35	universities	
were	selected	to	receive	grants.	This	included	11	items	in	medical	fields.
	 •	 universities	were	selected,	including	19	items	in	medical	fields.
Prepared by the STFC, referring to references[11 and12]
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(2)	 	“Program	for	Promotion	of	Training	of	High	
	 	Quality	Medical	Personnel	Responding	to
	 	Regional	Medicine	and	other	Social	Needs”[13]
The objectives of the “Program for Promotion 
of Training of High Quality Medical Personnel 
Responding to Regional Medicine and other 
Social Needs” (MEXT, Higher Education, Bureau, 
Medical Education Division) are to encourage a 
higher level of activity in university education 
and promote the training of the high quality 
medical personnel required by society. This 
promotion program provides financial support for 
distinctive outstanding programs for training high 
quality medical personnel from among programs 
in applications submitted by national, public, 
and private universities which have set themes 
responding to regional medicine and other social 
needs.[13]
Under this program, the announced themes 
for applications differ each year. The themes 
for F Y2006 were “Tra in ing of phys ic ians 
responding to unbalanced distribution by field” 
and “Training of pharmacists for improvement 
of clinical capabilities,” while those for FY2007 
were “Training of human resources for clinical 
research/research support” and “Encouraging 
female physicians/nurses to enter/remain in 
clinical work and support for return to work.”
The budget for the two themes in FY2007 
is ¥1.31 billion. Continuing financial support 
Table 4 : Examples of programs selected under the “Initiatives for Attractive Education
 in Graduate Schools” program (items related to clinical research)
Year 
selected University Specialization Educational program Object of program
2005 Gunma University
Graduate School of Medicine, 
Medical Science Course
Bilateral Evolution and Practice in 
Education in the Graduate School 
of Medicine
Fusion of basic medicine and 
clinical medicine
2005 Kyoto University Graduate School of Medicine
Horizontal Systematic Medical 
Research Career Path Formation
Interdisciplinary/integrated 
medical research
2005 Yamaguchi University
Graduate School of Medicine, 
Applied Medical Engineering 
Science Course
Education Program on Applied 
Medical Engineering Science 
(AMES)
Fusion of medicine and 
engineering
2005 Nagasaki University
Graduate School of Biomedical 
Sciences, Infection Research 
Course (Note: Emerging infectious 
disease pathology and control 
science)
International Infectious Disease 
Researcher/Medical Specialist 
Training Program
Training of infectious disease 
researchers and medical 
specialists
2006 Mie University
Graduate School of Medicine, Life 
and Medical Science Course
Training of Researchers in Medical 
Science/Therapeutics Responding 
to Region and Times
Fusion of basic and clinical 
research
2006 Kyushu University 
Department of Integrative 
Biomedical Sciences, Graduate 
School of Medical Sciences
Reform of Graduate School 
Education for Activation of Clinical 
Research
Specialized educational system for 
clinical research
2006 Kumamoto University 
Graduate School of Medical 
Science, Pathological Informatics 
Course
AIDS Researcher Training 
Program
Translational research related to 
AIDS
2006 Miyazaki University
Faculty of Medicine, Bioregulation 
Course
Educational Center Integrating 
Clinical Research and 
Translational Medicine
Translational medicine from 
discovery of seeds to clinical 
application
2006
Yokohama 
City 
University
Graduate School of Medicine, 
Biomolecular and Informatics 
Medical Science Course
Program for Training Clinical Trial 
Leaders Clinical trials and clinical tests
2006 Keio University
Graduate School of Medicine, 
Medical Science Course
Initiative for Integrated 
Master/Doctor Education for 
Encouragement of Cancer 
Research
Integrated basic and clinical 
research on cancer
Prepared by the STFC
20
S C I E N C E  &  T E C H N O L O G Y  T R E N D S
(approximately 3 years) is given to selected 
programs.
The object of the theme for 2007, “Training of 
human resources for clinical research/research 
support,” is for programs in connection with 
the training of high quality clinical researchers 
and research suppor t personnel (cl in ica l 
test coordinators, biostat ist icians, cl in ical 
epidemiologist, data managers, etc.) with the 
aim of fur ther promoting cl inical research 
contributing to drug discovery/development 
new therapeutic technologies and translational 
research to clinical research. 
The universities selected under the themes for 
FY2007 were announced on July 25, 2007. In the 
area of “Training of human resources for clinical 
research/research support,” 7 programs were 
selected from among 30 applications. It appears 
that programs which are expected to have 
practical and concrete effects were chosen. Table 
5 shows the programs selected.
4-3 Introduction of programs selected under
  “Initiatives for Attractive Education in
 Graduate Schools”
From Table 4, educational programs related 
to the following types of human resources for 
clinical research required in the future were 
selected: (A) Researchers who have strong ability 
in both basic research and clinical research, 
(B) Researchers oriented toward collaborative/
interdisciplinary research with other f ields, 
(C) Special ists in cl inical research, and (D) 
Researchers with a leadership role in clinical 
trials. The features of the selected programs are 
outlined below.
(A)	 	Training	of	 researchers	who	have	 strong	 ability	
in	both	basic	research	and	clinical	research
   °  I n te rd i s c ip l i n a r y Sy s tem at ic Med ica l 
Education Career Path Formation (Kyoto 
University)
[Background]
Considering the current rapid progress and 
international competition in medical research, 
strong social demand for return of research 
results to society, and similar factors, acquisition 
of more comprehensive, total medical knowledge 
and technology, acquisition of opinions and 
ethics that include cooperation with society, 
independence and originality that contribute 
to the development of new areas, and diverse 
international communications skills have become 
essential conditions.
[Objective]
The objective of this program is to construct 
a comprehensive and holistic graduate school 
education system including all persons, which 
rational ly introduces a wide perspective in 
Table 5 : Universities and programs selected for FY2007 Theme,
 “Training of Human Resources for Clinical Research/Research Support”
University Program
Gunma University Training of Human Resources for Clinical Testing by Postgraduate Integrated OJT
Kobe University
Reform of Clinical Research Education by Advanced CRESP
—  Development of Clinical Research Expert Specialization Program (CRESP) in the Kobe Local Medical 
Cluster —
Yamaguchi University Training of Human Resources for Support of Clinical Research by Graduate School Course
— Centering on the “Clinical Test Support Center” —
Kyushu University Training of Human Resources for Support of High Quality Doctor-Led Clinical Tests
— Creation of Infrastructure for Construction of Evidence for the Japanese People —
Ryukyus University Clinical Research Specialist Doctor and Top Class CRC Training Program
Jikei University Training of Primary Care Site Clinical Researchers
Kitasato University
Keio University
Juntendo University
Clinical Research Human Resource Training and Education Consortium
— Construction and Implementation of Education System through Domestic and International Collaboration —
Source: http://www.mext.go.jp/b_menu/houdou/19/07/07072516.htm
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education in line with the new environment 
of the times, while continuing to provide the 
intensive individual education given in traditional 
postgraduate education in medical fields in the 
past.
[Content of program]
   •  S i x e x i s t i n g f i e l d s o f  s p e c i a l i z a t i o n 
(physiology, pathology, internal medicine, 
surgery, molecular biology, and neuroscience) 
are unified in one integrated major course.
   •  In the integrated major course, in addition 
to the conventional field of specialization, 
12 graduate level courses cutting across 
basic, clinical, and social medicine are newly 
establ ished as a systematic educational 
curriculum unit. (These courses are Cell 
Biology/Cell Physiology, Development and 
Morphogenesis, Immunology, Allergy, and 
Infectious Diseases, Oncology, Genetic/
Genomic Medicine, Neuroscience, Lifestyle-
related Disease, Ag ing, and Metabol ic 
Medicine, Regenerative Medicine/Organ 
Reconstruction Medicine, Pathophysiology, 
Clinical Research (Clinical Epidemiology/
Cl in ica l Innovation), Health and Socia l 
M e d i c i n e ,  a n d M e d i c a l - E n g i n e e r i n g 
Collaboration).
   •  Students take at least one graduate school 
course while simultaneously belonging to 
their existing field of specialization, and carry 
out degree-related research while receiving 
education/research guidance from both 
systems until receiving their degree.
(Features and future expectations)
The program is expected to train researchers 
who have strong ability in both basic research 
and clinical research by providing an educational 
program that combines a horizontal element of 
specialized knowledge in a wide range of medical 
fields and a vertical element of deep expertise.
(B)	 Training	of	researchers	oriented	toward
	 collaborative/interdisciplinary	research	with
	 other	fields
   °  Medical-Engineering Integrated Practical 
Education Program (Yamaguchi University)
[Background]
The Yamaguchi University, Graduate School of 
Medicine, Applied Medical Engineering Sciences 
(AMES) Course is an independent specialized 
graduate school which was establ ished by 
merging the Medical School and Engineering 
Faculty in April 2001, and is the first school of 
its type in Japan. Its objective is to train human 
resources with the wide, creative vision necessary 
in developmental research on advanced medical 
devices and materials and theory, responding to 
new trends in medicine and welfare, based on 
digitization of biological information. It is the 
only graduate school in Japan which awards a 
medical engineering degree (Ph.D.).
[Objective]
The objective of AMES is to train researchers 
with rich humanity, who are creative, possess a 
wide vision, and can work actively internationally 
in the field of medical engineering. 
[Content of program]
   •  As required courses in the basic curriculum 
in medical engineering, classes in the basic 
medical curriculum are given for non-medical 
students (basic anatomy and physiology, 
basic biochemistry, basic pathology, medical 
statistics, basic internal medicine, basic 
surger y, etc.), and classes in the basic 
engineering curriculum are given for non-
engineer ing students (fundamenta ls of 
biomechanics, biosensing, biotargeting, 
biomaterials, biomimetics, biosystems, etc.).
   •  The second half of the Ph.D. course comprises 
a specialized medical engineering course and 
a developmental research course. Training 
in experimental and analytical techniques is 
given to enable students to develop integrated 
medical-engineering research.
   •  As motivation for medical engineer ing, 
persons from medical backgrounds learn the 
principles of advanced medical/analytical 
devices and gain engineering experience 
through practice in methods of use, while 
persons from engineering learn medical needs 
through clinical experience, for example, by 
seeing actual medical operations, etc.
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   •  The program trains “physicians who have 
knowledge of engineering” and “engineering 
researchers who are familiar with the field of 
medicine.”
(Features and expectations)
Linkage of medicine and engineering is no 
longer a new experiment. However, this type of 
program, which substantially integrates medical 
and engineering education and research with its 
focus narrowed to advanced medical equipment 
and materials is extremely novel and is expected 
to have an important effect.
(C)	Training	of	specialists	in	clinical	research	
   °  Reform of Graduate School Education for 
Activation of Cl inical Research (Kyushu 
University)
[Background]
Due to the rapid increase in the content of 
medical school education, introduction of the 
new system of clinical training after medical 
school graduation, etc., students and physician 
trainees no longer have the luxury of considering 
g r adu ate school educat ion. Under t hese 
conditions, graduate schools cannot fulfill their 
purpose of training human resources, creating 
obstacles to research.
[Objective]
Kyushu University wil l begin educational 
reform of its medical graduate school program 
with the creation of a specialized educational 
system for clinical research as the core element. 
Prior to respective technical field education, basic 
education covering the entire area of clinical 
research is first essential. Although it is necessary 
to train a large number of physicians for clinical 
research, young physicians must also acquire 
qualifications as specialists. For this reason, the 
creation of a system which allows physicians 
to attend graduate school as adult students is 
needed.
[Content of program]
   •  The creation of a specialized educational 
system for clinical research in the Ph.D. 
course and systematic course education will 
enable students to acquire the capability to 
perform proper clinical research.
   •  I n order to prov ide oppor tu n it ies for 
physicians to study in the graduate school as 
adult students, classes will be scheduled on 
evening or holidays.
   •  The specia l ized educational system for 
clinical research in the Ph.D. course and 
a basic researcher training system will be 
established, with free access to both systems.
(Features and expectations)
This program for training specialists in clinical 
research, which considers the personal career 
path as a physician, is expected to become a 
model program for encouraging physicians to go 
on to postgraduate education in the future.
(D)	Training	of	researchers	with	a	leadership	role	in
	 clinical	trials
   °  Program for Training Clinical Trial Leaders 
(Yokohama City University)
[Background]
To  o v e r c o m e  t h e  w e a k n e s s  o f  p o o r 
international competitiveness in clinical research 
in Japan, improvement of the system for clinical 
tests and new drug development/evaluation 
under physicians’ leadership is urgently needed in 
Japan.
[Objective]
The objective of this program is to train 
graduate students in graduate school Ph.D. 
courses as leaders who can widely develop 
clinical research and clinical tests in order to 
improve the clinical test system in Japan, raise 
the level of clinical therapeutics, and improve the 
system for safe and secure medical treatment.
[Content of program]
   •  Establishment of a systematic, individual 
guidance system, including basic knowledge, 
education, and cultivation of perspectives, 
spanning multiple fields of medical treatment 
and research.
   •  Establ i shment of an advanced medica l 
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research course and a clinical test expert 
course.
   •  The clinical test expert course wil l take 
the form of practice in performing clinical 
tests, and will make it possible to master the 
processes necessary to implement clinical 
tests and clinical trials.
   •  An agreement on cooperation in the training 
of human resources through development and 
implementation of an advanced joint scientific 
training program has been concluded with 
the Food and Drug Administration (FDA) in 
the United States, which is responsible for 
approving drugs in that country, and training 
at the FDA will be possible in the future.
   •  An international research education system 
is being introduced, for example, through a 
cooperation agreement with the University 
of Iowa in the US, which allows physicians 
licensed in Japan to practice medicine.
(Features and expectations)
This program is a graduate school specializing 
in the training of researchers (physicians) who 
will serve as leaders in clinical trials and clinical 
tests. Although this is the only graduate school 
in Japan with an actual course focusing on the 
training of clinical trial physicians, the number 
of graduate schools with this type of program is 
expected to increase in the future.
5 Conclusion
In spite of the continuing development of 
science and technology, as in the past, the 
number of issues facing medicine shows no 
signs of decreasing. Moreover, the structure of 
diseases is expected to become more complex 
in the future due to aging, changes in lifestyle 
and habits, and globalization. New challenges 
will include an increase in diseases that had been 
comparatively rare in the past, the appearance 
of new medica l condit ions and in fect ious 
diseases, and increased prevalence of compound 
diseases. Given these conditions, the needs and 
expectations for medical treatment will continue 
to increase.
The broad goals for medicine are to ensure that 
the Japanese people will receive better and more 
effective medical treatment than in the past in 
Japan, and at the same time, to enable progress in 
clinical research in this country. For this, it will 
be necessary to introduce new systems suited to 
the times in place of the conventional practices in 
actual medical treatment, in medical schools and 
other forms of education, and in research.
It takes more than 10 years after graduation 
from medical school for a physician to become 
fully qualified and experienced. Likewise, it 
also requires about 10 years to become a fully-
qualified basic researcher. In either case, whether 
for a physician or basic researcher, human 
resources development requires a lengthy period.
To confront today’s complex medical problems, 
human resources with wide clinical knowledge 
as physicians, a high level of special ization 
in medical treatment, advanced knowledge 
of research, and excellent research skills are 
necessary. Ideally, each individual should possess 
all of these qualifications, but in actuality, this 
may not be possible. It is nevertheless important 
to attempt to train diverse human resources 
with a breadth of expertise and high level of 
knowledge in universities. As discussed in this 
paper, various universities in Japan are beginning 
to implement distinctive training programs for 
human resources in the field of clinical research. 
As these have only begun, the results will not be 
apparent until some time in the future. However, 
the development of human resources who 
are both physicians and basic researchers is a 
challenge with which Japan must grapple from a 
long-term perspective.
Promotion of these types of human resources 
development programs in graduate schools at 
the national level will be extremely important 
for Japan in securing human resources with 
the high level of expertise necessary in the 
coming years. This is true of all fields, and not 
simply clinical research. In the future, it will 
be necessary to expand programs that support 
young researchers, including research funding 
and financial assistance for everyday needs, 
for individuals participating in these human 
resources development programs, in coordination 
with those programs.
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Glossary
*1 C l i n ica l r e s e a rch : Med ica l r e s e a rch 
implemented for the purpose of improving 
preventive methods, diagnostic methods, 
and therapeutic methods for diseases in 
medicine, understanding the pathogenesis 
and pathology of diseases, and improving 
the quality of life of patients (in addition 
to direct medical research, also includes 
r e s e a rch i n con nec t ion w i t h dent a l 
science, pharmacology, nursing science, 
rehabilitation science, preventive medicine, 
and health science) on human subjects 
(including research on materials and data 
of human origin which can designate an 
individual human).
 Source: Ethical Guidel ines for Cl inical 
Research (established July 30, 2004 by the 
Ministry of Health, Labour and Welfare).
*2 C l i n ica l tes t : Resea rch conducted i n 
accord a nce w i t h a n i mplement a t ion 
plan specified in advance by performing 
interventionary acts such as use of drugs, 
surgical operations, etc. on human subjects.
*3 Clinical trial : Clinical test performed for 
the purpose of obtaining the data necessary 
for application to the Ministry of Health, 
Labour and Welfare for approval of the 
manufacture, import, or sale of medical and 
pharmaceutical products, etc.
*4 Translational research :Clinical research 
on human subjects using small molecular 
compounds, polymer compounds, genes, 
cells, tissues, etc. when the appropriateness 
of human use has been confirmed publicly 
f rom both the e th ica l a nd sc ient i f ic 
viewpoints.
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